DianaVanDoMD
Ophthalmology • Stanford, CACataract Related, Retinal Disease
Professor of Ophthalmology, Vice Chair for Clinical Affairs, Byers Eye Institute, Stanford University School of Medicine
Dr. Do is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Summary
- Diana V. Do, MD, is Professor of Ophthalmology and Vice Chair for Clinical Affairs at the Byers Eye Institute at Stanford University School of Medicine. She has over 15 years of experience as a retinal surgeon. In addition, she is a physician-scientist who is a leader in clinical research and clinical trials of retinal vascular diseases.
Education & Training
Johns Hopkins UniversityFellowship, Surgical Retina and Vitreous, 2003 - 2005- Johns Hopkins UniversityResidency, Ophthalmology, 2000 - 2003
Massachusetts General HospitalInternship, Internal Medicine, 1999 - 2000
University of California San Francisco School of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2016 - 2026
NE State Medical License 2013 - 2018
MD State Medical License 2003 - 2014- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- The Effect of Macugen in Patients With Chronic, Post-Operative Cystoid Macular Edema Start of enrollment: 2006 Jul 01
- The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) Study Start of enrollment: 2006 Dec 01
- Age-related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study) Start of enrollment: 2007 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 75 citationsOcular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SA...Quan Dong Nguyen, Mohamed Ibrahim, Anthony Watters, Millena Bittencourt, Jithin Yohannan
Journal of Ophthalmic Inflammation and Infection. 2013-02-11 - 43 citationsOne-Year Outcomes of the SAVE Study: Sirolimus as a Therapeutic Approach for UVEitis.Mohamed Ibrahim, Yasir J. Sepah, Anthony Watters, Millena Bittencourt, Erin Vigil
Translational Vision Science & Technology. 2015-03-01 - 21 citationsThe Effect of Different Dosing Schedules of Intravitreal Sirolimus, a Mammalian Target of Rapamycin (mTOR) Inhibitor, in the Treatment of Non-Infectious Uveitis (An Am...Quan Dong Nguyen, Mohammad Ali Sadiq, Mohamed Kamel Soliman, Aniruddha Agarwal, Diana V. Do
Transactions of the American Ophthalmological Society. 2016-08-01
Press Mentions
AMD, DME Therapies Aimed at Reducing Treatment Burden Shine at AAO 2024November 1st, 2024- The Status of Gene Therapy Development for Retinal DiseasesApril 30th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
